229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.01%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-22.37%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-27.03%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-27.03%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-27.00%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-28.00%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-26.53%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.08%
Slight or no buybacks while VUZI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.12%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.16%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-46.62%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-51.34%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
2168.25%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
443.33%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
211.98%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
9690.16%
Positive long-term OCF/share growth while VUZI is negative. John Neff would see a structural advantage in sustained cash generation.
881.09%
Positive OCF/share growth while VUZI is negative. John Neff might see a comparative advantage in operational cash viability.
418.33%
Positive 3Y OCF/share CAGR while VUZI is negative. John Neff might see a big short-term edge in operational efficiency.
52224.57%
Positive 10Y CAGR while VUZI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
755.17%
Positive 5Y CAGR while VUZI is negative. John Neff might view this as a strong mid-term relative advantage.
199.97%
Positive short-term CAGR while VUZI is negative. John Neff would see a clear advantage in near-term profit trajectory.
2411.76%
Equity/share CAGR of 2411.76% while VUZI is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
602.52%
Equity/share CAGR of 602.52% while VUZI is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
232.58%
Positive short-term equity growth while VUZI is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-38.92%
Firm’s AR is declining while VUZI shows 0.63%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-14.43%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-0.69%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
6.31%
Positive BV/share change while VUZI is negative. John Neff sees a clear edge over a competitor losing equity.
No Data
No Data available this quarter, please select a different quarter.
10.79%
R&D dropping or stable vs. VUZI's 32.53%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-5.92%
We cut SG&A while VUZI invests at 28.69%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.